Cite
MLA Citation
V. Mazurov et al.. “OP0028 Efficacy and safety of bcd-085, a novel il-17 inhibitor, in ankylosing spondylitis. results of phase 2 clinical study.” Annals of the rheumatic diseases, vol. 77, n.d., p. 64. http://access.bl.uk/ark:/81055/vdc_100144715664.0x000050